Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection (ESSCALIVER)

This study has been completed.
Information provided by (Responsible Party):
Aesculap AG Identifier:
First received: June 9, 2009
Last updated: May 27, 2015
Last verified: May 2015